Previous close | 4.0500 |
Open | 4.0600 |
Bid | 3.9800 x 200 |
Ask | 3.9900 x 200 |
Day's range | 3.9700 - 4.1500 |
52-week range | 3.8700 - 8.0500 |
Volume | |
Avg. volume | 1,363,785 |
Market cap | 1.168B |
Beta (5Y monthly) | 0.36 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
In this article, we will take a detailed look at Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks. For a quick overview of such stocks, read our article Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 5 Stocks. Billionaire Stanley Druckenmiller is one of the most revered investors in the Wall Street. […]
Key Insights Institutions' substantial holdings in AbCellera Biologics implies that they have significant influence...
AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript February 20, 2024 AbCellera Biologics Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.14. AbCellera Biologics Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. […]